RA CAPITAL MANAGEMENT, L.P., DIR, reported an open-market or private purchase at Sionna Therapeutics, Inc. involving 102414.000000 shares for an estimated $1843452.00. Reported holdings after the transaction were 2324498.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
Form 4 relationship flags and nearby filing context
No officer title
Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (collectively the "Preferred Stock") converted into shares of Common Stock o…
Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), RA Capital Nexus III Fund, L.P. (the "Nexus Fund III"), and a separa…
Held directly by the Nexus Fund.
Held directly by Nexus Fund III.
Held directly by the Account.
0 other filings
0 recent txs